Loading clinical trials...
Loading clinical trials...
Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.
Clinical data (prostate-specific antigen \[PSA\] response after radiotherapy) are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.
Age
All ages
Sex
MALE
Healthy Volunteers
No
Cross Cancer Institute
Edmonton, Alberta, Canada
Start Date
February 1, 2004
Primary Completion Date
March 1, 2008
Completion Date
April 1, 2008
Last Updated
February 24, 2016
1,000
ACTUAL participants
Lead Sponsor
AHS Cancer Control Alberta
Collaborators
NCT06842498
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494